ProfileGDS4718 / 205233_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 74% 73% 43% 73% 71% 53% 48% 67% 78% 74% 74% 72% 62% 52% 48% 68% 77% 54% 57% 40% 66% 70% 78% 72% 66% 52% 74% 55% 76% 45% 59% 52% 71% 79% 46% 48% 51% 66% 69% 42% 76% 55% 56% 45% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.264374
GSM549102patient 115, normal, homogenized [OPG study]7.0490373
GSM549104patient 119, normal, homogenized [OPG study]5.1388943
GSM549108patient 138, normal, homogenized [OPG study]7.0899973
GSM549119patient 077, normal, homogenized [OPG study]6.9005971
GSM549133patient 032, cancer, homogenized [OPG study]5.6591353
GSM549139patient 042, cancer, homogenized [OPG study]5.3716248
GSM549099patient 107, normal, homogenized [OPG study]6.6081267
GSM549109patient 139, normal, homogenized [OPG study]7.5689978
GSM549110patient 046, normal, homogenized [OPG study]7.1696174
GSM549114patient 063, normal, homogenized [OPG study]7.2683274
GSM549122patient 082, normal, homogenized [OPG study]7.0183272
GSM549134patient 033, cancer, homogenized [OPG study]6.2150362
GSM549136patient 036, cancer, homogenized [OPG study]5.5903652
GSM549140patient 044, cancer, homogenized [OPG study]5.3705248
GSM549111patient 047, normal, homogenized [OPG study]6.7406168
GSM549113patient 057, normal, homogenized [OPG study]7.6131277
GSM549132patient 031, cancer, homogenized [OPG study]5.7417454
GSM549137patient 038, cancer, homogenized [OPG study]5.9393357
GSM549142patient 047, cancer, homogenized [OPG study]5.1343940
GSM549100patient 110, normal, homogenized [OPG study]6.5062766
GSM549107patient 135, normal, homogenized [OPG study]6.9032970
GSM549115patient 068, normal, homogenized [OPG study]7.6947278
GSM549116patient 072, normal, homogenized [OPG study]7.0844272
GSM549120patient 078, normal, homogenized [OPG study]6.5157266
GSM549131patient 030, cancer, homogenized [OPG study]5.5987352
GSM549118patient 074, normal, homogenized [OPG study]7.2811174
GSM549129patient 027, cancer, homogenized [OPG study]5.8439255
GSM549123patient 088, normal, homogenized [OPG study]7.4867876
GSM549124patient 006, cancer, homogenized [OPG study]5.2736845
GSM549126patient 015, cancer, homogenized [OPG study]6.0350859
GSM549128patient 025, cancer, homogenized [OPG study]5.6115752
GSM549103patient 117, normal, homogenized [OPG study]6.9197471
GSM549117patient 073, normal, homogenized [OPG study]7.7306879
GSM549138patient 041, cancer, homogenized [OPG study]5.2660346
GSM549141patient 045, cancer, homogenized [OPG study]5.3482948
GSM549130patient 028, cancer, homogenized [OPG study]5.576251
GSM549101patient 111, normal, homogenized [OPG study]6.5413766
GSM549105patient 128, normal, homogenized [OPG study]6.797269
GSM549106patient 134, normal, homogenized [OPG study]5.0570642
GSM549112patient 048, normal, homogenized [OPG study]7.4777776
GSM549125patient 011, cancer, homogenized [OPG study]5.828955
GSM549127patient 024, cancer, homogenized [OPG study]5.8926356
GSM549135patient 035, cancer, homogenized [OPG study]5.2148345